CMIC Group establishes biopharma CDMO in Japan

Single-use facility in Shizuoka, Japan has been established to provide process development and GMP manufacturing of antibody drugs using mammalian cell line

picture of

Breaking News

Metrics invests $10m in Greenville manufacturing facility

The $10m investment will add 3,760 sqft of production space to the current facility, providing added flexibility and ...

Hovione to support production of antiviral Veklury for COVID-19

Hovione has signed a partnership agreement with Ligand to significantly ramp up the production output of Captisol

CPhI Report predicts CGT capacity shortages in the USA and mAb approvals in China

Continuous bioprocessing is growing quickly ... but from a low base ... with virtually all manufacturers now using at ...

To build or buy: taking a pragmatic approach to outsourcing versus in-house manufacturing

A significant milestone in the life of any biotechnology company is deciding how to manufacture your biotherapeutic, ...

Metrics Contract Services begins $10 million plant expansion

Metrics, a full-service global contract development and manufacturing organisation (CDMO), commences construction on ...

T-knife and Catalent Sign to collaborate on autologous T-cell receptor-based cell therapy

Under the terms of the agreement, Catalent will undertake transfer of T-knife´s platform process for T-cell receptor- ...

Cleanroom Conference and Manufacturing Chemist Live events set to go ahead

The co-located events will go ahead in October with new safety measures in place, after being postponed from their ...

Abzena announced as best CRO at World ADC awards

Abzena is a leading partner research organisation that offers discovery, design, development and cGMP manufacture of ...

Asymchem and Snapdragon enter global partnership

The investment partnership has provided funding for Snapdragon to complete its expansion plan to build cGMP drug ...

Finding the perfect blend in contract manufacturing

Daniel Marr, Commercial Director of chemical manufacturer, Airedale Chemical, explains how the values and nature of ...

Delivering certainty in uncertain times

Contract manufacturing organisations (CMOs) in the pharmaceutical sector operate at the sharp end of an industry in ...

Reducing time-to-market with innovative approaches to analytical services

The way in which drug developers approach analytical chemistry can be crucial in terms of driving efficiencies in ...

LSNE expands aseptic fill finish capabilities in Europe

The news builds upon LSNE’s experience providing aseptic fill finish of biologic products for clients at its US ...

Merck announces $65m ADC manufacturing expansion

Completion is expected by mid-2022 and should add approximately 50 full-time jobs starting in 2021